Skip to main content
Equibles

NATIXIS

Position in BCYC — Bicycle Therapeutics PLC

CIK 1274981 PARIS, I0
Back to BCYC Full portfolio

Position in BCYC

as of Jun 30, 2026 · filed Aug 13, 2026
Position Value
$19,694
-$1,858 QoQ
Shares Held
4,645
0.0% QoQ
Ownership
0.007%
of shares outstanding
% of Portfolio
0.00%
of 13F equity value
Holder Rank
#82
of 103 holders
Holding Since
Dec 2022
15 quarters on record
Voting authority Sole 100% Shared 0% None 0%

Common Shares in BCYC Over Time

Shares Held

Position Value (USD)

Position in Biotechnology

Healthcare · as of Jun 30, 2026

NATIXIS holds $65,699,213 across 42 Biotechnology names. BCYC ranks #37 (0.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 VRTX
Vertex Pharmaceuticals Inc / Ma
 59,095 $29,354,259
2 CORT
Corcept Therapeutics Inc
 109,905 $9,556,239
3 EXEL
Exelixis, Inc.
 121,041 $6,585,840
4 MRNA
Moderna, Inc.
 66,370 $4,647,891
5 REGN
Regeneron Pharmaceuticals, Inc.
 6,599 $4,114,740
6 CAI
Caris Life Sciences, Inc.
 124,716 $2,222,439
7 RVMD
Revolution Medicines, Inc.
 8,467 $1,585,699
8 PTGX
Protagonist Therapeutics, Inc
 7,776 $953,182

All Filings in BCYC

Export CSV
15 filing rows on record
Report Date Value (USD) Shares
2026-06-30 $19,694 4,645
2026-03-31 $21,552 4,645
2025-12-31 $32,886 4,645
2025-09-30 $15,069 1,947
2025-06-30 $13,531 1,947
2025-03-31 $18,049 2,126
2024-12-31 $32,172 2,298
2024-09-30 $61,893 2,735
2024-06-30 $58,331 2,882
2024-03-31 $63,943 2,568
2023-12-31 $47,532 2,629
2023-09-30 $55,609 2,768
2023-06-30 $70,818 2,775
2023-03-31 $72,318 3,400
2022-12-31 $106,944 3,613